HI-Bio

Series-B
hibio.com Biotech & Healthcare South San Francisco, United States Founded 2021 11–50 employees
Total Funding $215M
Latest Round $95M Series-B
Last Announced Jan 4, 2024
Investors 7 Backers
Decision Makers 6 Available

About HI-Bio

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters South San Francisco, United States
Year Founded 2021
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website hibio.com
Domain Registered Date Undisclosed

Social & Network Presence

LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $95,000,000 · Series-B

    Backed by Alpha Wave Global

  2. Capital Raise

    Raised $120,000,000 · Series-A

    Backed by ARCH Venture Partners

  3. Milestone

    Company founded

    South San Francisco, United States

Investors & Backers

7
Alpha Wave Global
Lead
ARCH Venture Partners
Lead
Arkin Capital
Jeito Capital
Monograph Capital
MorphoSys
Viking Global Investors

Funding History

2 Rounds
Series-B equity · Jan 4, 2024

Round backers: Alpha Wave Global

Series-A equity · Nov 1, 2022

Round backers: ARCH Venture Partners

$120,000,000 vcnewsdaily.com

Founders & Leadership

6

Ariella Kelman

Senior Vice President of Development

Work email & phone locked Unlock →

Carl Enell

Chief Business Officer

Work email & phone locked Unlock →

Joyce Liaw

Vice President of Finance

Work email & phone locked Unlock →

Lorna Dean

Vice President of Clinical Operations

Work email & phone locked Unlock →

Matthew Albert

Chief Translational Officer

Work email & phone locked Unlock →

Travis Murdoch

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts